Search

Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2018

Optimizing Long-Term Visual Outcomes in Wet AMD

Carl D. Regillo, MD, Timothy G. Murray, MD, MBA

Show Description +

Carl D. Regillo, MD, joins Timothy G. Murray, MD, MBA, to discuss strategies for neovascular AMD. Dr. Regillo offers an overview of what retina specialists have learned since the advent of anti-VEGF therapies and stresses the importance of early diagnosis in long-term visual acuity. He also notes that all three anti-VEGF drugs are comparable in terms of efficacy and durability.

Posted: 3/07/2018

Keywords:

Anti-VEGF

•

Wet AMD

Up Next

Controversies in Vitreoretinal Surgery

Controversies in Vitreoretinal Surgery

Charles W.G. Eifrig, MD, Timothy G. Murray, MD, MBA

Advances in Retinal Drug Delivery

Advances in Retinal Drug Delivery

Robert L. Avery, MD, Timothy G. Murray, MD, MBA

Back Cutting Technique for Detached Retina

Back Cutting Technique for Detached Retina

Maria H. Berrocal, MD

27G Probe Technique for Peeling ERM/ILM

27G Probe Technique for Peeling ERM/ILM

Maria H. Berrocal, MD

Technique for Difficult TRD

Technique for Difficult TRD

Maria H. Berrocal, MD

Inside Out Vitrectomy Technique

Inside Out Vitrectomy Technique

Maria H. Berrocal, MD

ARDS Rewind

The Science Behind Advanced Surgical 3D Imaging

The Science Behind Advanced Surgical 3D Imaging

David R. Chow, MD, Timothy G. Murray, MD, MBA

Intravitreal Therapy for Retinal Diseases

Intravitreal Therapy for Retinal Diseases

Daniel F. Martin, MD, Timothy G. Murray, MD, MBA

Surgical Management of Complications of Diabetic Retinopathy

Surgical Management of Complications of Diabetic Retinopathy

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

Retinal Detachment in ROP Following Anti-VEGF Treatment

Retinal Detachment in ROP Following Anti-VEGF Treatment

Antonio Capone, Jr, MD, Timothy G. Murray, MD, MBA

Hypersonic Vitrectomy

Hypersonic Vitrectomy

Carl C. Awh, MD, Timothy G. Murray, MD, MBA

Back to All Videos

Optimizing Long-Term Visual Outcomes in Wet AMD

Carl D. Regillo, MD, Timothy G. Murray, MD, MBA

Carl D. Regillo, MD, joins Timothy G. Murray, MD, MBA, to discuss strategies for neovascular AMD. Dr. Regillo offers an overview of what retina specialists have learned since the advent of anti-VEGF therapies and stresses the importance of early diagnosis in long-term visual acuity. He also notes that all three anti-VEGF drugs are comparable in terms of efficacy and durability.

Posted: 3/07/2018

Keywords:

Anti-VEGF

•

Wet AMD

Please log in to leave a comment.

More From ARDS: 2018 Coverage

The Science Behind Advanced Surgical 3D Imaging

The Science Behind Advanced Surgical 3D Imaging

David R. Chow, MD, Timothy G. Murray, MD, MBA

Intravitreal Therapy for Retinal Diseases

Intravitreal Therapy for Retinal Diseases

Daniel F. Martin, MD, Timothy G. Murray, MD, MBA

Surgical Management of Complications of Diabetic Retinopathy

Surgical Management of Complications of Diabetic Retinopathy

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

Retinal Detachment in ROP Following Anti-VEGF Treatment

Retinal Detachment in ROP Following Anti-VEGF Treatment

Antonio Capone, Jr, MD, Timothy G. Murray, MD, MBA

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2018.